
Research area
Skin & Collagen
Copper-peptide and melanocortin-fragment research in skin, collagen and inflammation models.
Skin & Collagen references
Research updates
Recent developments
The latest dated changes for skin & collagen references. See all research updates.
HHS interim compounding policy
HHS published an enforcement-discretion policy covering BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 for licensed pharmacies and physicians. Comments close November 13, 2026.
Read the sourceExpert caution on clinical claims
A commentary in Aesthetic Surgery Journal warns that mechanistic plausibility is not clinical validation.
Read the sourceFDA advisory committee votes
FDA’s Pharmacy Compounding Advisory Committee voted on seven peptides over July 23–24, recommending six and declining emideltide (DSIP).
Read the sourceCategory 2 removals
FDA announced the removal of 12 peptide substances from its Category 2 compounding list, effective about April 22, 2026. Removal is not approval.
Read the source

